New-dol® 160 Suspension
New-dol® 160 Suspension
Fever reliever analgesic
Indication
New-dol® is indicated to relieve mild to moderate pain in many conditions as analgesic and antipyretic:
- New-dol® is indicated for symptomatic relief of headache, sore throat, rheumatic aches and pains, influenza, feverishness and feverish colds.
- In febrile conditions in children, teething, tonsillitis, measles aches and pain following vaccination or immunization.
- New-dol® is often the analgesic or antipyretic of choice especially in patients in whom salicylates or other NSAIDs are contra-indicated; such patients include asthmatics or children in whom salicylates are contra-indicated because of the risk of Reye’s syndrome.
Composition
Each 5 ml of New-dol® 120 oral suspension contains:
- Paracetamol 120 mg
Each 5 ml of New-dol® 160 oral suspension contains:
- Paracetamol 160 mg
Each 5 ml of New-dol® 250 oral suspension contains:
- Paracetamol 250 mg
Each 1 ml of New-dol® Infant drops contains:
- Paracetamol 100 mg
Dosage
Suspension:
- Infants (6–12 years): 5–10 ml of New-dol® 250, or 10 –15 ml of New-dol® 160.
- Children (1–5 years): 5–10 ml of New-dol® 120, or 5 –7.5 ml of New-dol® 160, or 5 ml of New-dol® 250.
- Infants (3–11 months): 2.5- 5 ml of New-dol® 120 or 2.5 ml of New-dol® 160
Infant Drops:
- Children (1–3 years): 1–2 ml.
- Infants (3–11 months): 1 ml.
- Infants under 3 months: the usual dose is 10 mg/kg of body weight (reduced to 5 mg/kg of body weight if jaundiced).
Note:
- Oral suspension and drops may be dosed every 4–6 hours if necessary.
Over dosage:
- Immediate medical managment is required in the events of overdose,even if symptoms of overdose aren’t present .
- paracetamol overdose may cause liver failure.
- Early symptoms may cause pallor, nausea ,vomiting, diaphoresis and general malaise.
- Overdose should be promptly treated by gastric lavage followed by IV N- acetylcystine or methionine without waiting for the results of plasma paracetamol levels.
- In all cases of suspected overdose, prompt medical attention is critical for adults , as well as for children, even if you don’t notice any signs or symptoms.
- Paracetamol is a para-aminophenol derivative, non-opioid, and nonsalicylate.
- Paracetamol has analgesic, antipyretic properties and weak anti-inflammatory activity.
- Paracetamol produces central and peripheral analgesia by elevation of the pain threshold and inhibition of prostaglandin biosynthesis; antipyretic action through action on the hypothalamic heat-regulating center, resulting in peripheral vasodilatation, increased blood flow through the skin, sweating and heat loss.
- Paracetamol is readily absorbed orally and rectally, the initial rapid response occurs in less than half an hour and within 2 hours peak levels are achieved.
Each 5 ml of New-dol® 120 oral suspension contains:
- Paracetamol 120 mg
Each 5 ml of New-dol® 160 oral suspension contains:
- Paracetamol 160 mg
Each 5 ml of New-dol® 250 oral suspension contains:
- Paracetamol 250 mg
Each 1 ml of New-dol® Infant drops contains:
- Paracetamol 100 mg
New-dol® is indicated to relieve mild to moderate pain in many conditions as analgesic and antipyretic:
- New-dol® is indicated for symptomatic relief of headache, sore throat, rheumatic aches and pains, influenza, feverishness and feverish colds.
- In febrile conditions in children, teething, tonsillitis, measles aches and pain following vaccination or immunization.
- New-dol® is often the analgesic or antipyretic of choice especially in patients in whom salicylates or other NSAIDs are contra-indicated; such patients include asthmatics or children in whom salicylates are contra-indicated because of the risk of Reye’s syndrome.
New-dol® is contra-indicated in:
- Hypersensitivity to Paracetamol.
- Chronic renal and/or hepatic diseases.
- New-dol® absorption may be accelerated by drugs such as metoclopramide, and may be reduced if given within one hour of cholestyramine.
- Probenecid can decrease paracetamol clearance and increase its plasma half life.
- The anticoagulant effect of warfarin and other coumarins may be enhanced by prolonged regular daily use of paracetamol with increased risk of bleeding.
- New-dol® has rare side effects at recommended dose. However, skin rash, other hypersensitivity reactions and hematological reactions occur occasionally.
- Hepatotoxicity after large dose or prolonged treatment.
Suspension:
- Infants (6–12 years): 5–10 ml of New-dol® 250, or 10 –15 ml of New-dol® 160.
- Children (1–5 years): 5–10 ml of New-dol® 120, or 5 –7.5 ml of New-dol® 160, or 5 ml of New-dol® 250.
- Infants (3–11 months): 2.5- 5 ml of New-dol® 120 or 2.5 ml of New-dol® 160
Infant Drops:
- Children (1–3 years): 1–2 ml.
- Infants (3–11 months): 1 ml.
- Infants under 3 months: the usual dose is 10 mg/kg of body weight (reduced to 5 mg/kg of body weight if jaundiced).
Note:
- Oral suspension and drops may be dosed every 4–6 hours if necessary.
Over dosage:
- Immediate medical managment is required in the events of overdose,even if symptoms of overdose aren’t present .
- paracetamol overdose may cause liver failure.
- Early symptoms may cause pallor, nausea ,vomiting, diaphoresis and general malaise.
- Overdose should be promptly treated by gastric lavage followed by IV N- acetylcystine or methionine without waiting for the results of plasma paracetamol levels.
- In all cases of suspected overdose, prompt medical attention is critical for adults , as well as for children, even if you don’t notice any signs or symptoms.
- New-dol® should be given with care to patients with impaired kidney or liver functions and in patients taking other drugs which may affect the liver.
- New-dol® Suspension: Bottles of 60 ml.
- New-dol® Drops: Bottles of 15 ml with insert dropper.
- Store in a dry place below 30 °C.